GLENCORE PLC/ADR (OTCMKTS:GLNCY) Cut to “Sell” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research downgraded shares of GLENCORE PLC/ADR (OTCMKTS:GLNCY) from a hold rating to a sell rating in a research note released on Thursday, Zacks.com reports.

According to Zacks, “Glencore Plc operates as a diversified natural resource company. It operates in three groups: Metals and Minerals, Energy Products, and Agricultural Products. The Metals and Minerals segment is involved in mining, smelting, refining, and warehousing copper, nickel, zinc/lead, alloys, alumina/aluminum and iron ore. The Energy Products segment includes controlled and non-controlled coal mining and oil production operations and investments in strategic handling, storage and freight equipment and facilities. The Agricultural Products segment focuses on grains, oils/oilseeds, cotton and sugar. The Company’s operations consist of mining and metallurgical sites, offshore oil production assets, farms and agricultural facilities. It is a producer and marketer of commodities, such as mobile phones, bicycles, cutlery, plastics and electricity. Glencore Plc, formerly known as Glencore Xstrata PLC, is headquartered in Baar, Switzerland. “

A number of other analysts have also recently weighed in on the stock. Royal Bank of Canada set a $30.00 price target on shares of Shaw Communications and gave the stock a buy rating in a research report on Wednesday, April 10th. Goldman Sachs Group raised shares of Martin Marietta Materials from a neutral rating to a buy rating and upped their price target for the stock from $207.00 to $232.00 in a research report on Thursday, April 11th. BMO Capital Markets cut shares of GLENCORE PLC/ADR from an outperform rating to a market perform rating in a research report on Wednesday, July 10th. Finally, UBS Group decreased their price target on shares of Broadcom from $325.00 to $310.00 and set a buy rating for the company in a research report on Friday, June 14th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of Hold and a consensus target price of $8.25.

Shares of GLENCORE PLC/ADR stock opened at $6.66 on Thursday. The business’s fifty day simple moving average is $6.74. The company has a current ratio of 1.10, a quick ratio of 0.59 and a debt-to-equity ratio of 0.59. GLENCORE PLC/ADR has a twelve month low of $6.31 and a twelve month high of $8.97. The stock has a market cap of $48.03 billion, a PE ratio of 10.41 and a beta of 1.82.

GLENCORE PLC/ADR Company Profile

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, energy products, and agricultural products. It operates in three segments: Metals and Minerals, Energy Products, and Agricultural Products. The Metals and Minerals segment is involved in smelting, refining, mining, processing, and storing zinc, copper, lead, alumina, aluminum, ferroalloys, nickel, cobalt, and iron ore.

Recommended Story: What Are Treasury Bonds?

Get a free copy of the Zacks research report on GLENCORE PLC/ADR (GLNCY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for GLENCORE PLC/ADR (OTCMKTS:GLNCY)

Receive News & Ratings for GLENCORE PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GLENCORE PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases AvalonBay Communities  Price Target to $224.00
JPMorgan Chase & Co. Increases AvalonBay Communities Price Target to $224.00
Brightsphere Investment Group  Lifted to “Hold” at Zacks Investment Research
Brightsphere Investment Group Lifted to “Hold” at Zacks Investment Research
PLDT  Rating Lowered to Hold at Zacks Investment Research
PLDT Rating Lowered to Hold at Zacks Investment Research
AtriCure  Stock Rating Lowered by Northland Securities
AtriCure Stock Rating Lowered by Northland Securities
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine


 
© 2006-2019 Zolmax.